QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,320 signal articles · 410 in last 24h · 107,324 total before filter · latest 29m ago
410last 24h
2514last 7d
494● bullish (7d)
239● bearish (7d)
200publishers
AllMacro215Earnings1549M&A125Regulatory16Product9Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
ASML (ENXTAM:ASML) Just Raised Its Interim Dividend 17% And Backed 2026 Guidance
Simply Wall St.3d agoneutral
ASML (ENXTAM:ASML) Just Raised Its Interim Dividend 17% And Backed 2026 Guidance

ASML Holding raised its interim dividend by 17% year over year, signaling confidence in its cash generation. The company paired the dividend move with strong 2026 revenue guidance, despite ongoing China related risks. The new payout level points to a strengthening income profile for shareholders alongside ASML’s leadership in chipmaking tools. ASML Holding, ticker ENXTAM:ASML, is reinforcing its income story with a higher interim dividend and firmer guidance. The stock trades at €1,419.6,...

Did Strong Q2 Earnings and an Analyst Upgrade Just Shift Generac Holdings' (GNRC) Investment Narrative?
Simply Wall St.3d agobullish
Did Strong Q2 Earnings and an Analyst Upgrade Just Shift Generac Holdings' (GNRC) Investment Narrative?

In late July 2026, Generac Holdings Inc. reported second-quarter 2026 results showing sales of US$1,173.51 million and net income of US$143.24 million, with both basic and diluted earnings per share from continuing operations rising compared with the same period a year earlier, and it also maintained its full-year 2026 net sales growth guidance in the mid-to-high teens percent range. Alongside these results, a subsequent upgrade to a top-tier analyst rating, driven by higher earnings...

BioNTech Q2 Earnings Call Highlights
MarketBeat3d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt

Palantir Technologies shares surge after earnings beat
Proactive3d agobullish
Palantir Technologies shares surge after earnings beat

Palantir Technologies Inc (NYSE:PLTR) shares jumped 20% to about $152 in early trade on Tuesday the company reported second quarter 2026 results that exceeded Wall Street expectations for both earnings and revenue. The company reported adjusted earnings per share of $0.41, compared with the...